14 Oct 2020 Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion Member news
13 Oct 2020 Phase 2B/3 Trial shows efficacy of Filgotinib for the induction and maintenance of remission in moderately and severely active Ulcerative Colitis Member news
13 Oct 2020 Sanquin finds investors for plasma-derived medicines manufacturing subsidiaries Plasma Industries and Plasma Products Member news
09 Oct 2020 BISC Global awarded a Eurostars grant for the development of a machine learning based antigen discovery and T-cell epitope prediction software. Member news
08 Oct 2020 eTheRNA strengthens senior management team with appointment of Michael Mulqueen as VP Business Development Member news
07 Oct 2020 Complix receives €1.2 million VLAIO grant to develop a novel and differentiated class of anti-Covid-19 Alphabody™ therapeutics Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
